Lupin achieves S&P Global ESG Score of 91 for 2025, surpassing pharma industry average
Lupin reports a 91-point S&P Global ESG Score for 2025, exceeding the pharma industry average of 28 and marking a major rise…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lupin receives EIR from U.S. FDA for Aurangabad facility
The Establishment Inspection Report follows a product-specific Pre-Approval Inspection conducted by the U.S. FDA at Lupin’s…
THSTI, Miltenyi Biotec and BIRAC launch India’s first hands-on training on cell and gene therapy…
The initiative focuses on building India’s capacity in CAR-T cell therapy through practical training and industry-academia…
Lupin manufacturing solutions commissions dedicated oncology block at Vizag facility
Lupin Manufacturing Solutions has commissioned a new high-containment oncology unit at its Vizag site to expand contract…
Novo Nordisk India reduces Wegovy prices by 37% to expand access for people
Novo Nordisk India has reduced the weekly price of the starting dose of Wegovy from INR 4,336 to INR 2,712, aiming to make…
A biosimilar boost amid trade barriers
Even as India’s biggest pharma companies pursue biosimilars, product recalls related to manufacturing defects threaten to queer…
Servier India launches biomarker testing initiative for AML and Cholangiocarcinoma patients
The programme is introduced in collaboration with MedGenome and Strand Life Sciences to expand access to molecular testing across…
Zydus receives NMPA approval in China for Venlafaxine extended-release capsules
This marks the first NMPA approval for Zydus in the Chinese market
SPDS to conduct Dissolution Science training programme for regulators in collaboration with DCGI,…
The training is scheduled for 12 November 2025 at CDSCO, Mumbai
Glenmark Specialty secures NMPA approval for RYALTRIS nasal spray
Commercialisation to be undertaken by Grand Pharmaceuticals under existing exclusive licensing agreement